DTAB Seeks State Input on Unified Licensing Authority

The Drugs Technical Advisory Board (DTAB) of the Union Health Ministry has proposed that the Drugs Consultative Committee (DCC) collect opinions from various states on creating a single licensing and approval authority in India.

Macau Approves Everest Medicines' Velsipity for Severe Ulcerative Colitis

Everest Medicines is a biopharmaceutical company specializing in developing, manufacturing, and commercializing new medicines and vaccines.

Galimedix's GAL-201 Shows Alzheimer's Neuroprotection at AD/PD 2024

Galimedix Therapeutics, Inc. has announced encouraging results for its small-molecule compound, GAL-201, which has the potential to revolutionize the treatment of eye and brain malignancies. The company is a Phase 2 biotech that develops

Revamped PTUAS: Enhanced Subsidies for MSME Pharmaceutical Upgrades

The Department of Pharmaceuticals (DoP) has revamped the Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) sub-scheme with significant changes, including reimbursement subsidies of around 10-20 percent for upgrading quality

Sukino Healthcare: NABH Certification for Care Centre

Sukino Healthcare Solutions, a continuing care provider, has received National Accreditation Board for Hospitals and Healthcare Providers (NABH) accreditation for one of its continuing care centers.

Supriya Lifescience Empowers Women in India's $5 Trillion Goal

In a landmark declaration aligning with International Women's Day, Supriya Lifescience Ltd., a distinguished global manufacturer of active pharmaceutical ingredients (APIs), has underscored the indispensable contribution of women to India's

Apollo Hospitals Introduces ZAP-X for Brain Tumor Treatment in South Asia

Apollo Hospitals Group, India’s largest integrated healthcare provider, recently unveiled the ZAP-X gyroscopic radiosurgery platform, a revolutionary advancement in brain tumor treatment, marking a significant milestone as the first in South Asia.

Kathua: North India's Holistic Healthcare Hub - Dr. Jitendra

Union Minister in PMO with independent charge of Science and Technology, Dr Jitendra Singh, today announced that Rs 80 crore Centrally funded North India’s first Government Homoeopathic Medical College.

Kerala DCA Initiates 'Operation Double-Check' Against Drug Procurement Sources

The Drug Control Administration (DCA) in Kerala plans to launch ‘Operation Double-Check’ involving all drug inspectors in the districts to ensure the quality of drugs imported from other states and to find out the sources of drug procurement

US FDA Nods expanded use of BeiGene's Blood Cancer Drug

The U.S. Food and medication Administration has granted fast approval for BeiGene's combo medication to treat some patients with a kind of blood cancer, the health authority announced.The oral medication Brukinsa, in combination with Roche's Gaz...

© 2024 India Pharma Outlook. All Rights Reserved.